Sonic Healthcare rallied 10% higher from today’s open price.
Although Sonic has withdrawn its FY20 earnings guidance, (EBITDA
growth 6-8% cc) due to COVID-19, the company has a strong balance sheet with $1bn of cash and committed credit facilities available with no debt facilities maturing until 2021.
You're not a member! Trial today
